Cite

HARVARD Citation

    Li, R. et al. (2018). Comparison of Toxicity and Efficacy Outcomes of Capecitabine/MMC and 5FU/MMC in Patients with Bladder Cancer Treated with Radical Chemoradiotherapy. Clinical oncology. 30 (3), pp. 197-. [Online]. 
  
Back to record